Hypertension associated with kidney disease is a predictive factor for preeclampsia

  • Preeclampsia is a pregnancy-specific disease with multisystem involvement and high morbidity and mortality, which begins with high blood pressure (HTA) and signs of liver or kidney damage in pregnant women from the 20th week of pregnancy
  • Specialists in nephrology, obstetrics, and family medicine (Primary Care) in Barcelona recommend coordination in the management of HTA during pregnancy to identify its origin and control associated risk factors
  • Several studies confirm that the combination of HTA and kidney disease is a predictive factor for suffering from preeclampsia and that, in the long term, having suffered from it increases the risk of developing severe cardiovascular disease

Barcelona, May 22, 2023.- In the framework of the 24th Nephrology and Primary Care Conference, organized by the Hypertension and Kidney Disease Prevention Unit of Fundació Puigvert, the need for coordinated and multidisciplinary care for pregnant women presenting HTA has been highlighted as it may be associated with kidney disease and be a predictive factor for suffering from preeclampsia. Furthermore, experts confirm that women who have suffered an obstetric complication such as preeclampsia will have a high risk of developing cardiovascular diseases such as HTA, diabetes, obesity, and thromboembolism, among other pathologies.

Preeclampsia is a pregnancy-specific disease with multisystem involvement (especially, kidney, liver, and brain), defined as hypertension that appears from 20 weeks of gestation. Currently, it is necessary to perform screening tests on all pregnant women, and the screening for early preeclampsia in the first trimester has been included in the Pregnancy Follow-up Protocol in Catalonia since 2018.

The Dr. Elisa Llurba, director of the Gynecology and Obstetrics Service at Sant Pau Hospital and Head of the Perinatal and Women’s Medicine Group at the Sant Pau Hospital Research Institute – IIB Sant Pau, stated that “at Sant Pau Hospital we have a Preeclampsia Screening Program that is carried out based on maternal clinical history (for example, having suffered from it previously), along with high blood pressure and evaluation of blood flow in the uterine arteries. This screening can identify 65-70% of women who will develop preterm preeclampsia.”

Pregnancy, HTA, and kidney disease

One of the most common cases in the nephrology consultation at Fundació Puigvert is that of women with autosomal dominant polycystic kidney disease (ADPKD), the most frequent hereditary kidney disease, when they express the desire for pregnancy. It is a congenital disease that is

diagnosed through first-degree family history and is ruled out through an ultrasound. The Dr. Patrícia Fernández-Llama, Head of the Hypertension Unit of the Nephrology Service at Fundació Puigvert, states that “women with kidney diseases have a higher risk of serious complications for both themselves and the future baby. This is why obstetricians and nephrologists at Sant Pau Hospital and Fundació Puigvert, respectively, work together in a multidisciplinary consultation to address these high-risk pregnancies: if the pregnancy is planned with stabilized kidney disease, the risk of complications is reduced because it allows us to anticipate and apply early intervention strategies to minimize risks.”

Preeclampsia, a precursor to cardiovascular disease

A retrospective study by the Catalan Health Institute (ICS) in the city of Barcelona has recorded a total of 1976 episodes of preeclampsia in 1329 women (some had two or more episodes) in the last twenty years. The analysis and follow-up of these patients during this period reveal that women who have suffered one or more episodes of preeclampsia develop severe cardiovascular diseases such as HTA, diabetes, obesity, cardiovascular events, and even kidney disease, much more frequently than women who have never presented preeclampsia.

The conclusion remains the same: good communication and coordination between patients, family doctors, obstetricians, and nephrologists for the detection, control, and follow-up of women of reproductive age with HTA and pregnancy desire is vital to prevent preeclampsia and its associated morbidity and mortality.